Fulgent Genetics, Inc. (FLGT): Shareholders' Equity
$1.11B
As of 2025-12-31
$1.00B
As of 2026-06-30
-4.2%
3-year compound annual growth
+14.3%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.11B | -1.9% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $1.13B | -0.3% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $1.14B | -10.3% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $1.27B | +9.3% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $1.16B | +103.5% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $569.39M | +587.9% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $82.78M | +61.8% | 2021-03-08, Balance as of period end |
| 2018-12-31 | $51.15M | -5.6% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $54.18M | -0.6% | 2019-03-22, Balance as of period end |
| 2016-12-31 | $54.48M | +958.7% | 2018-03-20, Balance as of period end |
| 2015-12-31 | $5.15M | +205.6% | 2017-03-17, Balance as of period end |
| 2014-12-31 | $1.68M | n/a | 2017-03-17, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.11B | -1.9% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $480.11M | n/m |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $470.87M | +3.3% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $303.10M | -19.9% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.31B | +11.4% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.58B | +3.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $577.31M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$99.31M | n/m |
| Biodesix Inc (BDSX) | 2025-12-31 | -$2.46M | n/m |
Compare FLGT, BLLN, CSTL, CDNA side by side · Screen every company in Services-Medical Laboratories ↗